Related Experiment Videos
Multifunctional nanoparticles self-assembled from polyethylenimine-based graft polymers as efficient anticancer drug
Jianqin Yan1, Ting Su1, Furong Cheng1
1National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, People's Republic of China.
Colloids and Surfaces. B, Biointerfaces
|April 18, 2017
Summary
This study developed pH-sensitive nanoparticles for targeted cancer drug delivery. Hyaluronic acid-coated nanoparticles effectively released doxorubicin in cancer cells, showing potent anticancer activity.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Nanoparticle functionalization is crucial for effective drug delivery.
- Developing targeted and stimuli-responsive systems enhances therapeutic efficacy.
Purpose of the Study:
- To synthesize and characterize multifunctional nanoparticles for targeted anticancer drug delivery.
- To evaluate the pH-sensitive drug release and tumor-targeting capabilities of hyaluronic acid-coated nanoparticles.
Main Methods:
- Synthesis of polymeric amphiphiles via Schiff's reaction.
- Self-assembly into pH-sensitive nanoparticles loaded with doxorubicin.
- Coating nanoparticles with hyaluronic acid for tumor targeting.
- In vitro evaluation of drug release, cellular uptake, and cytotoxicity.
Main Results:
- Synthesized nanoparticles exhibited pH-sensitivity and a mean size of approximately 100nm.
- Hyaluronic acid coating enhanced nanoparticle disassembly in acidic conditions, leading to faster doxorubicin release at pH 5.0.
- Nanoparticles demonstrated endosomal escape, accelerating drug release within cancer cells.
- Effective killing of breast cancer (4T1) and liver cancer (HepG2) cells in vitro with low IC50 values.
Conclusions:
- The developed hyaluronic acid-coated nanoparticles are promising for targeted and pH-responsive doxorubicin delivery.
- The nanoparticles show efficient endosomal escape and significant in vitro anticancer activity.
- This approach offers a potential strategy for improving cancer therapy outcomes.